Palbociclib

Palbociclib is a member of the class of pyridopyrimidines that is 2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7-one bearing additional methyl, acetyl and cyclopentyl substituents at positions 5, 6 and 8 respectively. It is used in combination with letrozole for the treatment of metastatic breast cancer. It is grouped under the following drug class(es): Antineoplastic agents, CDK4/6 Inhibitors and Kinase inhibitors. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ibrance and palbociclibum. Its PubChem CID is 5330286.

CAS No 571190-30-2
Molecular Formula C24H29N7O2
Molecular Weight 447.5 g/mol
Synonyms 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one

Frequently Asked Questions